Author: Shakiba, Maryam; Nazemipour, Maryam; Salari, Arsalan; Mehrabian, Fardin; Nazari, Seyed Saeed H.; Rezvani, Seyed Mahmoud; Ghasempour, Zahra; Heidarzadeh, Abtin; Mansournia, Mohammad Ali
Title: Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 Cord-id: zod8q73a Document date: 2021_2_25
ID: zod8q73a
Snippet: We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%).
Document: We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%).
Search related documents:
Co phrase search for related documents- actual prevalence and acute phase: 1
- acute phase and additional information: 1
- acute phase and low sensitivity: 1, 2, 3, 4, 5, 6
- additional information and low sensitivity: 1
Co phrase search for related documents, hyperlinks ordered by date